Fabian Tenenbaum - Net Worth and Insider Trading
Fabian Tenenbaum Net Worth
The estimated net worth of Fabian Tenenbaum is at least $1,195 dollars as of 2024-11-13. Fabian Tenenbaum is the CEO of Bellerophon Therapeutics Inc and owns about 32,286 shares of Bellerophon Therapeutics Inc (BLPH) stock worth over $1,195. Details can be seen in Fabian Tenenbaum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fabian Tenenbaum has not made any transactions after 2019-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fabian Tenenbaum
Fabian Tenenbaum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fabian Tenenbaum owns 1 companies in total, including Bellerophon Therapeutics Inc (BLPH) .
Click here to see the complete history of Fabian Tenenbaum’s form 4 insider trades.
Insider Ownership Summary of Fabian Tenenbaum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BLPH | Bellerophon Therapeutics Inc | 2019-05-21 | Chief Executive Officer |
Fabian Tenenbaum Latest Holdings Summary
Fabian Tenenbaum currently owns a total of 1 stock. Fabian Tenenbaum owns 32,286 shares of Bellerophon Therapeutics Inc (BLPH) as of May 21, 2019, with a value of $1,195.
Latest Holdings of Fabian Tenenbaum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BLPH | Bellerophon Therapeutics Inc | 2019-05-21 | 32,286 | 0.04 | 1,195 |
Holding Weightings of Fabian Tenenbaum
Fabian Tenenbaum Form 4 Trading Tracker
According to the SEC Form 4 filings, Fabian Tenenbaum has made a total of 0 transactions in Bellerophon Therapeutics Inc (BLPH) over the past 5 years. The most-recent trade in Bellerophon Therapeutics Inc is the acquisition of 333 shares on May 21, 2019, which cost Fabian Tenenbaum around $3,000.
Insider Trading History of Fabian Tenenbaum
- 1
Fabian Tenenbaum Trading Performance
GuruFocus tracks the stock performance after each of Fabian Tenenbaum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fabian Tenenbaum is 3.44%. GuruFocus also compares Fabian Tenenbaum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fabian Tenenbaum within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fabian Tenenbaum's insider trading performs compared to the benchmark.
Performance of Fabian Tenenbaum
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.59 | | | | | |
| Relative Return to S&P 500(%) | 2.58 | | | | | |
Fabian Tenenbaum Ownership Network
Ownership Network List of Fabian Tenenbaum
Ownership Network Relation of Fabian Tenenbaum
Fabian Tenenbaum Owned Company Details
What does Bellerophon Therapeutics Inc do?
Who are the key executives at Bellerophon Therapeutics Inc?
Fabian Tenenbaum is the Chief Executive Officer of Bellerophon Therapeutics Inc. Other key executives at Bellerophon Therapeutics Inc include 10 percent owner Puissance Life Science Opportunities Fund Vi , VP of Business Operations Parag Suresh Shah , and See Remarks Martin Dekker .
Bellerophon Therapeutics Inc (BLPH) Insider Trades Summary
Over the past 18 months, Fabian Tenenbaum made no insider transaction in Bellerophon Therapeutics Inc (BLPH). Other recent insider transactions involving Bellerophon Therapeutics Inc (BLPH) include a net sale of 694,421 shares made by Puissance Capital Fund (gp) Llc , a net sale of 1,076,841 shares made by Puissance Life Science Opportunities Fund Vi , and a net sale of 9,455 shares made by Bobae Kim .
In summary, during the past 3 months, insiders sold 0 shares of Bellerophon Therapeutics Inc (BLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,780,717 shares of Bellerophon Therapeutics Inc (BLPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,780,717 shares.
Bellerophon Therapeutics Inc (BLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bellerophon Therapeutics Inc Insider Transactions
Fabian Tenenbaum Mailing Address
Above is the net worth, insider trading, and ownership report for Fabian Tenenbaum. You might contact Fabian Tenenbaum via mailing address: 60 East 42nd Street, Suite 1160, New York Ny 10165.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
